BG105331A - Бензотиено[3,2-c]пиридини, като алфа 2 - антагонисти - Google Patents
Бензотиено[3,2-c]пиридини, като алфа 2 - антагонистиInfo
- Publication number
- BG105331A BG105331A BG105331A BG10533101A BG105331A BG 105331 A BG105331 A BG 105331A BG 105331 A BG105331 A BG 105331A BG 10533101 A BG10533101 A BG 10533101A BG 105331 A BG105331 A BG 105331A
- Authority
- BG
- Bulgaria
- Prior art keywords
- benzothieno
- pyridines
- alpha2
- alpha2 antagonists
- alkanediyil
- Prior art date
Links
- 239000000670 adrenergic alpha-2 receptor antagonist Substances 0.000 title abstract 2
- RQMWVVBHJMUJNZ-UHFFFAOYSA-N 4-chloropyridin-2-amine Chemical compound NC1=CC(Cl)=CC=N1 RQMWVVBHJMUJNZ-UHFFFAOYSA-N 0.000 title 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- -1 nitro, hydroxy Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Изобретението се отнася до съединения с формула до техните N-оксиди, фармацевтично приемливи присъединителни соли и стереохимични изомерни форми. Въвформулата всеки R1 e независимо водород, халоген,С1-6-алкил, нитро, хидрокси или С1-4-алкилокси; Alk e С1-6-алкандиил; n има стойност 1 или 2; р имастойност 0, 1 или 2; D е евентуално заместен моно-, би- или трицикличен азот, съдържащ хетероцикъл,който има централна алфа2-адреноцепторна антагонистична активност. Изобретението се отнася също до тяхното получаване, до състави, които ги съдържат,и до употребата им като лекарствени средства.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98203363 | 1998-10-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BG105331A true BG105331A (bg) | 2001-11-30 |
| BG64625B1 BG64625B1 (bg) | 2005-09-30 |
Family
ID=8234188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG105331A BG64625B1 (bg) | 1998-10-06 | 2001-03-12 | Бензотиено[3,2-c]пиридини, като алфа 2 - антагонисти |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US6426350B1 (bg) |
| EP (1) | EP1117667B1 (bg) |
| JP (1) | JP4580555B2 (bg) |
| KR (1) | KR20010071828A (bg) |
| CN (1) | CN1158287C (bg) |
| AR (1) | AR023678A1 (bg) |
| AT (1) | ATE363485T1 (bg) |
| AU (1) | AU760226B2 (bg) |
| BG (1) | BG64625B1 (bg) |
| BR (1) | BR9913110A (bg) |
| CA (1) | CA2346084C (bg) |
| CZ (1) | CZ20011103A3 (bg) |
| DE (1) | DE69936219T2 (bg) |
| EE (1) | EE04835B1 (bg) |
| ES (1) | ES2288025T3 (bg) |
| HU (1) | HUP0103612A3 (bg) |
| ID (1) | ID28280A (bg) |
| IL (2) | IL142442A0 (bg) |
| NO (1) | NO20011309D0 (bg) |
| NZ (1) | NZ509911A (bg) |
| PL (1) | PL347184A1 (bg) |
| RU (1) | RU2222542C2 (bg) |
| SK (1) | SK4312001A3 (bg) |
| TR (1) | TR200100954T2 (bg) |
| TW (1) | TWI251595B (bg) |
| UA (1) | UA70334C2 (bg) |
| WO (1) | WO2000020422A1 (bg) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2359136T3 (es) * | 2002-03-08 | 2011-05-18 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Uso de inhibidores de la transactivación de egfr en cáncer humano. |
| ATE521593T1 (de) * | 2002-04-03 | 2011-09-15 | Orion Corp | Verwendung eines alfa2-adrenorezeptorantagonisten bei mit dem zns zusammenhängenden erkrankungen |
| WO2005100355A1 (ja) | 2004-04-12 | 2005-10-27 | Taisho Pharmaceutical Co., Ltd. | 環状アミン化合物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3752820A (en) | 1972-03-20 | 1973-08-14 | Colgate Palmolive Co | Substituted-1,2,3,4-tetrahydrobenzothieno(3,2-c)pyridine derivatives |
| FR2570701B1 (fr) | 1984-09-27 | 1987-05-22 | Synthelabo | Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique |
| US4686226A (en) * | 1985-09-03 | 1987-08-11 | Merck & Co., Inc. | Substituted benzo[b]furo- and benzo[b]thieno quinolizines |
| US4985422A (en) * | 1988-04-27 | 1991-01-15 | Glaxo Group Limited | Lactam derivatives |
| US5100891A (en) * | 1991-01-18 | 1992-03-31 | Hoechst-Roussel Pharmaceuticals Inc. | Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds |
| GB9106179D0 (en) * | 1991-03-22 | 1991-05-08 | Sandoz Ltd | Improvements in or relating to organic compounds |
| DE69531476T2 (de) * | 1994-09-12 | 2004-06-09 | Lilly Industries Ltd., Basingstoke | Serotonergische Modulatoren |
| JP3274579B2 (ja) * | 1995-01-12 | 2002-04-15 | 住友製薬株式会社 | 脳血管障害に伴う精神症候治療剤 |
| UA52681C2 (uk) * | 1997-04-08 | 2003-01-15 | Янссен Фармацевтика Н.В. | Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі |
-
1999
- 1999-01-10 UA UA2001031998A patent/UA70334C2/uk unknown
- 1999-10-01 DE DE69936219T patent/DE69936219T2/de not_active Expired - Lifetime
- 1999-10-01 TW TW088116899A patent/TWI251595B/zh not_active IP Right Cessation
- 1999-10-01 CN CNB998116777A patent/CN1158287C/zh not_active Expired - Fee Related
- 1999-10-01 RU RU2001111753/04A patent/RU2222542C2/ru not_active IP Right Cessation
- 1999-10-01 SK SK431-2001A patent/SK4312001A3/sk unknown
- 1999-10-01 WO PCT/EP1999/007418 patent/WO2000020422A1/en not_active Ceased
- 1999-10-01 TR TR2001/00954T patent/TR200100954T2/xx unknown
- 1999-10-01 EP EP99947469A patent/EP1117667B1/en not_active Expired - Lifetime
- 1999-10-01 IL IL14244299A patent/IL142442A0/xx active IP Right Grant
- 1999-10-01 EE EEP200100206A patent/EE04835B1/xx not_active IP Right Cessation
- 1999-10-01 ES ES99947469T patent/ES2288025T3/es not_active Expired - Lifetime
- 1999-10-01 HU HU0103612A patent/HUP0103612A3/hu unknown
- 1999-10-01 ID IDW20010781A patent/ID28280A/id unknown
- 1999-10-01 US US09/806,432 patent/US6426350B1/en not_active Expired - Lifetime
- 1999-10-01 AT AT99947469T patent/ATE363485T1/de not_active IP Right Cessation
- 1999-10-01 BR BR9913110-2A patent/BR9913110A/pt not_active Application Discontinuation
- 1999-10-01 KR KR1020017000400A patent/KR20010071828A/ko not_active Ceased
- 1999-10-01 CA CA2346084A patent/CA2346084C/en not_active Expired - Fee Related
- 1999-10-01 NZ NZ509911A patent/NZ509911A/xx unknown
- 1999-10-01 AU AU60899/99A patent/AU760226B2/en not_active Ceased
- 1999-10-01 JP JP2000574534A patent/JP4580555B2/ja not_active Expired - Fee Related
- 1999-10-01 CZ CZ20011103A patent/CZ20011103A3/cs unknown
- 1999-10-01 PL PL99347184A patent/PL347184A1/xx not_active Application Discontinuation
- 1999-10-05 AR ARP990105039A patent/AR023678A1/es active IP Right Grant
-
2001
- 2001-03-12 BG BG105331A patent/BG64625B1/bg unknown
- 2001-03-15 NO NO20011309A patent/NO20011309D0/no not_active Application Discontinuation
- 2001-04-04 IL IL142442A patent/IL142442A/en not_active IP Right Cessation
-
2002
- 2002-04-16 US US10/123,338 patent/US6774129B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0638567A4 (en) | ADENOSINE INHIBITORS. | |
| ZA984640B (en) | 9-Azabicyclo[3.3.1]non-2-ene and nonane derivatives their preparations and use | |
| HUP0300641A2 (hu) | Triazaspiro[5.5]undekán-származékok és hatóanyagként ezeket tartalmazó gyógyszerkészítmények | |
| MX9804849A (es) | Derivados de benzazepina. | |
| BG104148A (bg) | Производни на индол и 2,3-дихидроиндол, тяхното получаване и приложение | |
| MY120033A (en) | 1,2,3,4- tetrahydro- benzofuro[3,2-c] pyridine derivatives | |
| CA2337825A1 (en) | Disubstituted bicyclic heterocycles, the preparation thereof and their use as pharmaceutical compositions | |
| ES8702903A1 (es) | Un procedimiento para preparar un compuesto de piperazina | |
| MY129176A (en) | Tetrahydro gamma-carbolines | |
| CA2244777A1 (en) | 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors | |
| DK0888337T3 (da) | Piperidon-tachykininantagonister | |
| CA2254755A1 (en) | Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs | |
| BG105332A (bg) | Трициклични делта 3-пиперидини, като алфа долу 2 -антагонисти | |
| BG105855A (bg) | 2 - аминопиридини съдържащи заместители със свързан пръстен | |
| BG105331A (bg) | Бензотиено[3,2-c]пиридини, като алфа 2 - антагонисти | |
| IL75165A0 (en) | Dihydropyridines and pharmaceutical compositions containing them | |
| ES8800905A1 (es) | Un procedimiento para la preparacion de nuevos derivados de dihidroisoquinolina | |
| IL74556A (en) | Derivatives of 1,5-diaryl-1,2,4-thiadiazine 1-oxide,their preparation and pharmaceutical compositions containing them | |
| IL91541A0 (en) | Aryloxy-,arylthio-,heteroaryloxy-,and heteroarylthioalkenylene derivatives of amines,their preparation and pharmaceutical compositions containing them | |
| PL338009A1 (en) | 2,4,4-three-substituted 1,3-dioxolane based antimycotic agents | |
| DE3660959D1 (de) | Benz-trisubstituted 2-aminotetralins | |
| IL88573A (en) | 2-plasmin inhibitor depressant, urokinase secretion accelerator or thrombolytic composition comprising trihydroxypiperidine derivatives, nojirimycin or castanospermine | |
| SU1282506A1 (ru) | 2-(3',4',5'-триметоксифенил)-1-метилимидазо (4,5-с)пиридингидрохлорид, обладающий спазмолитической и гипотензивной активностью | |
| PT84005A (en) | 6h-isoxazol]3,4-d"pyrazolo]3,4-b"pyridines a process and intermediates for their preparation and their use as medicaments |